We are thrilled to share a major milestone for our pipeline: the first patient has been treated in the FOCUS-01 Phase 1 trial of AVA6103 (FAP-Exd), our sustained-release pre|CISION® exatecan peptide drug conjugate. https://t.co/sGGbU7vQHZ #AVCT#FOCUSontheWIN
#AVCT “Further, the Company will provide a business update on the date of the Annual General Meeting, on July 2, 2025” Doesn’t everyone always get a business update at an AGM? So why the pointless inclusion… Hint Hint! 👀
Avacta announces a new partial response observed in a patient with salivary gland cancer in the dose expansion phase of the FAP-Dox (AVA6000) Phase 1b trial. https://t.co/tlLANUQCEl #AVCT
@MylesMcNulty@boy_cellar Yet another example. I think it goes to show there has most likely been several 'offers' for #AVCT from interested parties, with probably some very entertaining figures (enough to cause a frenzy on here) yet a long way off where the BoD know's this can go after further trials.
@Keir_Starmer@NCA_UK Great news. ‘A man’ has been arrested in connection with the over 100k illegal immigrants that have arrived so far since 2018 across the channel. Gangs smashed. Job done. 🤡
@BethRigby@BethRigby & those that ARE working people (PAYE) that can afford to replace a broken boiler (because they were diligent savers) are not actually working people either! Can we just get rid of the elephant in the room. The Middle classes are about to shoulder the burden.
@BethRigby@FT@BethRigby Before you even get on to shares etc It’s important to note that a lot of ‘working people’ ie PAYE (like you) are NOT working people by his definition either. So it’s a flawed definition. They don’t want to say ‘working class’ people. Middle class workers watch out!
@BethRigby@MailOnline@BethRigby More to the point: Anybody that works hard and doesn’t ‘struggle’ to write a ‘cheque’ if the boiler breaks down is NOT a working person either. They omit the word ‘class’ now. It’s ’working CLASS people’ & the ‘middle’ class (not the ‘rich’) will pay in this budget..
@ShareProphets 2 key logical points really:
1) No more payment in shares to HCI which = Possibly one more monthly cash payment or settlement in FULL by the next round.
=2) Deal in the pipeline. Possibly sale of Dx &/ some licensing of the pipeline.
Both huge catalysts for #AVCT
@ShareProphets They haven’t woken up this morning & thought, oh let’s just randomly burn some much needed cash instead of a bit of minor dilution for no intelligent reason then let’s go back to paying in shares next month have they… It’s now crystal clear they’re advancing a deal.. #AVCT
#AVCT
To me @avacta - a clinical stage life sciences firm developing innovative ‘Smart Chemo’ treatments (re cancer) & diagnostics - is clearly confident in its future cashflow, R&D pipeline and commercialisation strategy.
Today saying that it had decided to settle its quarterly convertible bond repayment (Re £2.55m principle & £0.58m interest) in cash, rather than stock as has previously been the case.
Adding that it also remains "on track to achieve its stated corporate objectives for H2'24, namely to update the clinical data in the AVA6000 programme, to initiate enrolment in the expansion cohorts of the Phase 1 trial and disclose the updated pipeline."
As a result, the principal on the convertible debt falls to £33.15m.
#AVCT forget finite funds reduced and minor dilution averted… As clearly not much logic in them doing either. Think WHY? WHY NOW, THIS MONTH? It’s obvious there’s something BIG in the pipeline… A very strong H2 ahead of us 💪🏽
@UKLabour About fucking time… If you actually listened to him you’d note he keeps referring to the French system which like the UK is universal for all, & it’s citizens (according to the WHO) get the "best overall health care" in the world. The model here is broken & needs ‘Reform’.
In the new R&D Spotlight Series we will take you a little deeper into the science behind the Avacta Therapeutics pipeline. In the first episode today we're going to introduce you to two of our key chemists who are working on the preCISION platform. https://t.co/jK9lGjBNJF #AVCT
@sharesearch_#AVCT That was part of my point.. 75.8p yesterday. Clearly from well above 100p, corruption has seen who knew about this short it & sell out to buy lower. Everything then snowballs from there. That’s obviously driven down the strike price for days. This is the AIM environment.
#AVCT After all the “optionality”, a raise at 34% discount to the sp yesterday for a pathetic £13.8m at 50p & AS can’t even chip in £20k. Fucking terrible. & people wonder why AIM is fucked. Stocks should be suspended for placings just like on ASX etc. So many knew & exploited.